Improving biosafety and biosecurity measures for the COVID-19 diagnostic in Madagascar – IBBM

IBBM is a project aimed at improving the local diagnostic COVID-19 diagnostic capacity of the CHU of Mahajanga. Mahajanga is located on the west-northern coast of Madagascar at more than 2 days travel distance from the capital city Antananarivo. There the most of the diagnostic activities are centralized in the capital and in order to better respond to the pandemic, a decentralized diagnostic frame is crucial. A diagnostic laboratory has been established but biosafety and biosecurity measures must be brought to higher quality standards. The overall objective of IBBM is to improve the biosafety and biosecurity measures at the COVID-19 diagnostic unit of the CHU of Mahajanga.

Partners: University of Mahajanga

@BNITM Dewi Ismajani Puradiredja - Eva Mertens - Ricardo Strauss (iACE)

Funding:

Federal Foreign Office (BfAA)

Duration:

October 2020 - CLOSED

Ein Pfleger steht an einem Whiteboard und skizziert eine Übersicht.
IBBM - Biosafety and biosecurity training at the Centre Hospitalier of Mahajanga (Madagascar).   ©BNITM l Jean-Marc Kutz

AG Implementationsforschung

Daniela Fusco, Ph.D.: eine Forscherin vor dunklen roten Backstein Hintergrund, die ihre blonden schulterlangen Haar offen trägt.
Department of Infectious Disease Epidemiology

PhD Daniela Fusco

phone: +49 40 285380-504

email: fusco@bnitm.de

  • [Translate to English:] GHPP logo
  • [Translate to English:] EDCTP logo
  • [Translate to English:] COR NTD logo
  • [Translate to English:] Else Kröner Fresenius Stiftung Logo
  • [Translate to English:] DZIF logo
  • [Translate to English:] Hospital Partnership logo
  • [Translate to English:] GLOHRA logo
  • [Translate to English:] Federal Foreign Office